Jeffrey Meckler
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jeffrey Meckler
Jeffrey Meckler is recorded as CEO at Indaptus Therapeutics, Inc. (INDP). The proxy statement of Indaptus Therapeutics, Inc. reports total compensation of $1,412,237 for Jeffrey Meckler in fiscal 2021, including a base salary of $540,000. Disclosed compensation is on record for 2 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2021-07-23–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Indaptus Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- David E. Lazar CEO, Chairman
- David Lazar CEO, Chairman, Board Member
- Jeffrey A. Meckler CEO, Board Member
- Junyi Dai CEO, Chairman, Board Member
- Roger J. Pomerantz Chairman, Board Member
- Yu Ding CFO
- Walt A. Linscott COO
- Anthony J. Maddauluna Board Member
- Avraham Ben-Tzvi Board Member
- David Natan Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Indaptus Therapeutics, Inc. (INDP) | Chief Executive Officer | $540,000 | $1,412,237 |
| 2020 | Indaptus Therapeutics, Inc. (INDP) | Chief Executive Officer | $540,000 | $1,066,243 |
Recent activity
No call appearances or filed executive changes recorded yet.